The insulin-suppressive effect of resveratrol — An in vitro and in vivo phenomenon
- 1 February 2008
- journal article
- Published by Elsevier in Life Sciences
- Vol. 82 (7-8), 430-435
- https://doi.org/10.1016/j.lfs.2007.12.008
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Resveratrol enhances insulin secretion by blocking KATP and KV channels of beta cellsEuropean Journal of Pharmacology, 2007
- Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic ratsLife Sciences, 2007
- Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1αCell, 2006
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Toxicogenomics of resveratrol in rat liverLife Sciences, 2005
- Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transductionOncogene, 2003
- Inhibition of mitochondrial proton F0F1‐ATPase/ATP synthase by polyphenolic phytochemicalsBritish Journal of Pharmacology, 2000
- Metabolic remission with octreotide in patients with insulinomaJournal of Internal Medicine, 1994
- Studies on the local (paracrine) actions of glucagon, somatostatin and insulin in isolated islets of rat pancreasFEBS Letters, 1980
- IMPROVEMENT IN INSULIN SECRETION IN DIABETES AFTER DIAZOXIDEThe Lancet, 1976